- The trend backdrop is active with a 12-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
CHEMBONDCH
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Chembond Chemicals Limited · Basic Materials · Specialty Chemicals
Latest close
237.4 INR
4.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 35.5% above the Trend Line and sits at 76.4% of its 52-week range. The latest completed week returned 4.9%, after a -1.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.
Setup score
66
out of 100
Latest Close
237.4 INR
7 Aug 2026
1W Return
4.9%
latest completed week
4W Return
-1.9%
short-term follow-through
12W Return
31.2%
quarterly tape
Trend Breadth
23.1%
12 of 52 weeks active
Volume Ratio
1.9x
vs 13-week average
- 3 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.9%
Latest completed week; four-week move -1.9%.
Indicator stack
54/79
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
51/100
27 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 35.5% above the Trend Line and sits at 76.4% of its 52-week range. The latest completed week returned 4.9%, after a -1.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8812-week average 0.68
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.88Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers
No recent accumulation markers. 3 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -1.9% over four weeks, 31.2% over 12 weeks, and 35.2% over one year. The current trend has remained active for 12 consecutive weeks.
Performance by holding period
Active trend streak12 weeks
Active weeks in one year12
Trend breadth23.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.60Latest activity-pressure read.
Pressure change7.1%Four-week change in activity pressure.
Leadership39.28Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength89/100Blend of value, momentum, and quality. Underlying universe rank 12; rank 1 is best.
Value68/100Relative valuation strength. Underlying universe rank 33; rank 1 is best.
Quality63/100Profitability and accounting quality. Underlying universe rank 38; rank 1 is best.
Momentum86/100Medium-term price momentum. Underlying universe rank 15; rank 1 is best.
Growth41/100Revenue and earnings growth. Underlying universe rank 60; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework80/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 17.5x Price divided by trailing earnings.
- Price / sales
- 1.9x Market value relative to trailing revenue.
- EV / EBITDA
- 11.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 50.3% Gross profit retained from each unit of revenue.
- Operating margin
- 12.8% Operating profit retained from revenue.
- Free-cash-flow margin
- 0.4% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 11.6% Latest one-year revenue growth.
- EPS growth
- 12.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -73.6% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.5% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 27 relevant articles.
9 positive · 15 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.7%Distance below the 52-week high.
13-week volatility6.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+25.4%Week of 3 Apr.
Worst week-12.4%Week of 27 Mar.
Latest week+4.9%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains4
Flat weeks0
Modest losses6
Sharp losses7
Recent vol6.8%13-week weekly-return volatility.
Base vol7.9%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew6.8% / -4.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank75 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape64/100
Trend, activity pressure, participation, and risk combine to a 64/100 tape read.
Indicator analysis71/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 4/12.
Activity pressure 0.88; 3 reversal markers Factors76/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 28; Small Cap Core rank 47 SVQF80/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 322.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 27 relevant articles.
Chembond Chemicals AGM votes approve dividend and related-party deals Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 237.4 INR | 4.9% | 175.2 INR | 172.0 INR | 1.60 | 39.28 | 106.6K | On |
| 31 Jul 2026 | 226.4 INR | -8.5% | 172.3 INR | 170.8 INR | 1.65 | 34.76 | 63.6K | On |
| 24 Jul 2026 | 247.4 INR | 3.0% | 169.8 INR | 169.8 INR | 1.71 | 51.81 | 58.8K | On |
| 17 Jul 2026 | 240.3 INR | -0.6% | 166.8 INR | 168.3 INR | 1.64 | 45.05 | 95.4K | On |
| 10 Jul 2026 | 241.9 INR | 6.3% | 164.1 INR | 166.9 INR | 1.49 | - | 113.3K | On |
| 3 Jul 2026 | 227.5 INR | 1.4% | 161.4 INR | 165.4 INR | 1.20 | - | 17.6K | On |
| 26 Jun 2026 | 224.5 INR | 10.5% | 159.0 INR | 164.1 INR | 1.03 | - | 0 | On |
| 19 Jun 2026 | 203.2 INR | 17.7% | 156.5 INR | 162.9 INR | 0.99 | - | 8.3K | On |
| 12 Jun 2026 | 172.6 INR | -4.5% | 155.0 INR | 162.0 INR | 1.11 | - | 5.2K | On |
| 5 Jun 2026 | 180.8 INR | -2.4% | 154.1 INR | 161.8 INR | 1.23 | - | 9.9K | On |
| 29 May 2026 | 185.3 INR | -3.4% | 153.2 INR | 161.3 INR | 1.34 | - | 68.1K | On |
| 22 May 2026 | 191.9 INR | 6.0% | 152.3 INR | 160.8 INR | 1.24 | - | 120.2K | On |
| 15 May 2026 | 180.9 INR | -3.4% | 151.1 INR | 160.1 INR | 1.08 | - | 71.0K | Off |
| 8 May 2026 | 187.3 INR | 23.1% | 150.1 INR | 159.6 INR | 0.97 | - | 366.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.